secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001493152-24-023096
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Heng Fai Ambrose Chan resigns; Jason T. Grady appointed to board
-------------------------------------------------------------------------

- Heng Fai Ambrose Chan resigned as director effective June 6, 2024, with no disagreement.
- Board appointed Jason T. Grady as director effective June 6, 2024.
- Grady is COO of DSS, Inc., President of Premier Packaging, President/COO of DSS Wealth Management and BioLife Science.
- No arrangement or understanding regarding Grady's appointment; no family relationship or related party transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/0001493152-24-023096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000149315224023096/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer